Glucotrol and Hyperplasia - a phase IV clinical study of FDA data

Summary:

Hyperplasia is reported as a side effect among people who take Glucotrol (glipizide), especially for people who are male, 60+ old, also take Glucophage, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hyperplasia when taking Glucotrol. It is created by eHealthMe based on reports of 20,197 people who have side effects when taking Glucotrol from the FDA, and is updated regularly.

What is Glucotrol?

Glucotrol has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 20,322 Glucotrol users. Check the latest studies of Glucotrol.

What is Hyperplasia?

Hyperplasia (enlargement of an organ or tissue) is found to be associated with 314 drugs and 427 conditions by eHealthMe. Check the latest studies of Hyperplasia.

On Jul, 13, 2026

20,197 people reported to have side effects when taking Glucotrol.
Among them, 23 people (0.11%) have Hyperplasia.

Among these 23 people:

What is the gender of people who have Hyperplasia when taking Glucotrol? *

female: 8.7 %
male: 91.3 %

What is the age of people who have Hyperplasia when taking Glucotrol? *

What are other drugs people take besides Glucotrol? *

What are other side effects people have besides Hyperplasia? *

Inflammation: 17 people, 73.91%
Tooth Disorder (tooth disease): 17 people, 73.91%
Toothaches (tooth pain): 16 people, 69.57%
Fainting (loss of consciousness and postural tone): 16 people, 69.57%
Purulent Discharge (discharge that contains pus): 16 people, 69.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 69.57%
Discomfort: 16 people, 69.57%
Osteomyelitis (infection of bone): 16 people, 69.57%
Excessive Granulation Tissue (excessive collagen-rich tissue which forms at the site of an injury): 16 people, 69.57%
Weakness: 15 people, 65.22%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 69.57%
Insomnia (sleeplessness): 3 people, 13.04%
Skin Ulcer: 1 person, 4.35%
Metastases To Bone (cancer spreads to bone): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Glucotrol and have Hyperplasia?

- Check whether Hyperplasia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucotrol:

Glucotrol (20,322 reports)

Hyperplasia treatments and more:

Hyperplasia (1,530 reports)

Browse all side effects of Glucotrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperplasia:

Hyperplasia (314 drugs)

Browse all the conditions that are associated with Hyperplasia:

Hyperplasia (427 conditions)

Related publications that referenced our studies

Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on glipizide (the active ingredients of Glucotrol) and Glucotrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.